Cargando…

Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation

Atrial fibrillation (AF)–associated remodeling includes contractile dysfunction whose reasons are only partially resolved. Serotonin (5-HT) increases contractile force and causes arrhythmias in atrial trabeculae from patients in sinus rhythm (SR). In persistent atrial fibrillation (peAF), the force...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolce, Bernardo, Christ, Torsten, Grammatika Pavlidou, Nefeli, Yildirim, Yalin, Reichenspurner, Hermann, Eschenhagen, Thomas, Nikolaev, Viacheslav O., Kaumann, Alberto J, Molina, Cristina E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835186/
https://www.ncbi.nlm.nih.gov/pubmed/32949251
http://dx.doi.org/10.1007/s00210-020-01968-1
_version_ 1783642461178953728
author Dolce, Bernardo
Christ, Torsten
Grammatika Pavlidou, Nefeli
Yildirim, Yalin
Reichenspurner, Hermann
Eschenhagen, Thomas
Nikolaev, Viacheslav O.
Kaumann, Alberto J
Molina, Cristina E
author_facet Dolce, Bernardo
Christ, Torsten
Grammatika Pavlidou, Nefeli
Yildirim, Yalin
Reichenspurner, Hermann
Eschenhagen, Thomas
Nikolaev, Viacheslav O.
Kaumann, Alberto J
Molina, Cristina E
author_sort Dolce, Bernardo
collection PubMed
description Atrial fibrillation (AF)–associated remodeling includes contractile dysfunction whose reasons are only partially resolved. Serotonin (5-HT) increases contractile force and causes arrhythmias in atrial trabeculae from patients in sinus rhythm (SR). In persistent atrial fibrillation (peAF), the force responses to 5-HT are blunted and arrhythmic effects are abolished. Since force but not arrhythmic responses to 5-HT in peAF could be restored by PDE3 + PDE4 inhibition, we sought to perform real-time measurements of cAMP to understand whether peAF alters PDE3 + PDE4-mediated compartmentation of 5-HT(4) receptor-cAMP responses. Isolated human atrial myocytes from patients in SR, with paroxysmal AF (paAF) or peAF, were adenovirally transduced to express the FRET-based cAMP sensor Epac1-camps. Forty-eight hours later, cAMP responses to 5-HT (100 μM) were measured in the absence or concomitant presence of the PDE3 inhibitor cilostamide (0.3 μM) and the PDE4 inhibitor rolipram (1 μM). We successfully established real-time cAMP imaging in AF myocytes. 5-HT increased cAMP in SR, paAF, and peAF, but in line with previous findings on contractility, this increase was considerably smaller in peAF than in SR or paAF. The maximal cAMP response to forskolin (10 μM) was preserved in all groups. The diminished cAMP response to 5-HT in peAF was recovered by preincubation with cilostamide + rolipram. We uncovered a significantly diminished cAMP response to 5-HT(4) receptor stimulation which may explain the blunted 5-HT inotropic responses observed in peAF. Since both cAMP and force responses but not arrhythmic responses were recovered after concomitant inhibition of PDE3 + PDE4, they might be regulated in different subcellular microdomains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00210-020-01968-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7835186
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-78351862021-01-29 Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation Dolce, Bernardo Christ, Torsten Grammatika Pavlidou, Nefeli Yildirim, Yalin Reichenspurner, Hermann Eschenhagen, Thomas Nikolaev, Viacheslav O. Kaumann, Alberto J Molina, Cristina E Naunyn Schmiedebergs Arch Pharmacol Original Article Atrial fibrillation (AF)–associated remodeling includes contractile dysfunction whose reasons are only partially resolved. Serotonin (5-HT) increases contractile force and causes arrhythmias in atrial trabeculae from patients in sinus rhythm (SR). In persistent atrial fibrillation (peAF), the force responses to 5-HT are blunted and arrhythmic effects are abolished. Since force but not arrhythmic responses to 5-HT in peAF could be restored by PDE3 + PDE4 inhibition, we sought to perform real-time measurements of cAMP to understand whether peAF alters PDE3 + PDE4-mediated compartmentation of 5-HT(4) receptor-cAMP responses. Isolated human atrial myocytes from patients in SR, with paroxysmal AF (paAF) or peAF, were adenovirally transduced to express the FRET-based cAMP sensor Epac1-camps. Forty-eight hours later, cAMP responses to 5-HT (100 μM) were measured in the absence or concomitant presence of the PDE3 inhibitor cilostamide (0.3 μM) and the PDE4 inhibitor rolipram (1 μM). We successfully established real-time cAMP imaging in AF myocytes. 5-HT increased cAMP in SR, paAF, and peAF, but in line with previous findings on contractility, this increase was considerably smaller in peAF than in SR or paAF. The maximal cAMP response to forskolin (10 μM) was preserved in all groups. The diminished cAMP response to 5-HT in peAF was recovered by preincubation with cilostamide + rolipram. We uncovered a significantly diminished cAMP response to 5-HT(4) receptor stimulation which may explain the blunted 5-HT inotropic responses observed in peAF. Since both cAMP and force responses but not arrhythmic responses were recovered after concomitant inhibition of PDE3 + PDE4, they might be regulated in different subcellular microdomains. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00210-020-01968-1) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-09-19 2021 /pmc/articles/PMC7835186/ /pubmed/32949251 http://dx.doi.org/10.1007/s00210-020-01968-1 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Dolce, Bernardo
Christ, Torsten
Grammatika Pavlidou, Nefeli
Yildirim, Yalin
Reichenspurner, Hermann
Eschenhagen, Thomas
Nikolaev, Viacheslav O.
Kaumann, Alberto J
Molina, Cristina E
Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
title Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
title_full Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
title_fullStr Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
title_full_unstemmed Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
title_short Impact of phosphodiesterases PDE3 and PDE4 on 5-hydroxytryptamine receptor4-mediated increase of cAMP in human atrial fibrillation
title_sort impact of phosphodiesterases pde3 and pde4 on 5-hydroxytryptamine receptor4-mediated increase of camp in human atrial fibrillation
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835186/
https://www.ncbi.nlm.nih.gov/pubmed/32949251
http://dx.doi.org/10.1007/s00210-020-01968-1
work_keys_str_mv AT dolcebernardo impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT christtorsten impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT grammatikapavlidounefeli impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT yildirimyalin impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT reichenspurnerhermann impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT eschenhagenthomas impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT nikolaevviacheslavo impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT kaumannalbertoj impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation
AT molinacristinae impactofphosphodiesterasespde3andpde4on5hydroxytryptaminereceptor4mediatedincreaseofcampinhumanatrialfibrillation